Azithromycin and the risk of cardiovascular death [7]

New England Journal of Medicine

Volumn 367, Issue 8, 2012, Pages 774-775

  Dos Santos, Rodrigo Pires ^a   Kuchenbecker, Ricardo ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; PLACEBO;

ACUTE SINUSITIS; BRONCHITIS; CARDIOVASCULAR RISK; DRUG INDICATION; DRUG USE; EAR INFECTION; HEART DEATH; HUMAN; LETTER; NOSE INFECTION; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; CARDIOVASCULAR DISEASE; FEMALE; MALE; MORTALITY; NOTE; SUDDEN DEATH;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE;

EID: 84865302911     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1207269     Document Type: Letter

References (4)

1. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008;2:CD000243.
2. Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012;307:685-92.
3. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2004;1:CD000219.
4. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004;4:CD000245.